| Genentech, Inc. |
Level III |
4 | 4 |
$144,050 |
| Gilead Sciences, Inc. |
Level IV |
4 | 4 |
$159,360 |
| Gilead Sciences, Inc. |
Level II |
3 | 3 |
$101,546 |
| Issam Tina Solutions, Inc. |
Level II |
3 | 3 |
$116,688 |
| NTESS LLC |
Level I |
3 | 3 |
$110,000 |
| Amgen Inc. |
Level IV |
2 | 2 |
$170,206 |
| Frontage Laboratories, Inc. |
Level II |
2 | 2 |
$107,877 |
| Gilead Sciences, Inc. |
Level III |
2 | 2 |
$142,101 |
| Hexagon Bio, Inc. |
Level III |
2 | 2 |
$144,059 |
| IsoRx Corp. |
Level I |
2 | 2 |
$78,270 |
| Lawrence Livermore National Security, LLC |
Level III |
2 | 2 |
$184,477 |
| Leland Stanford Jr. Univ/SLAC National Accelerator Lab |
Level I |
2 | 2 |
$83,075 |
| Meadowhawk Biolabs, Inc. |
Level II |
2 | 2 |
$105,658,613 |
| MRL San Francisco, LLC |
Level III |
2 | 2 |
$131,400 |
| ZymoChem, Inc. |
Level IV |
2 | 2 |
$150,275 |
| Alamar Biosciences, Inc. |
Level IV |
1 | 1 |
$221,860 |
| Alcon Research, LLC |
Level I |
1 | 1 |
$78,270 |
| Allure Labs, LLC |
Level II |
1 | 1 |
$113,000 |
| Amyris, Inc. |
Level III |
1 | 1 |
$124,842 |
| AnaSpec, Inc. |
Level I |
1 | 1 |
$78,270 |
| Apertor Pharmaceuticals Inc. |
Level IV |
1 | 1 |
$180,000 |
| Arcus Biosciences, Inc. |
Level III |
1 | 1 |
$164,700 |
| Arcus Biosciences, Inc. |
Level IV |
1 | 1 |
$152,300 |
| Bureau Veritas Commodities and Trade, Inc. |
Level III |
1 | 1 |
$124,842 |
| Circle Pharma, Inc. |
Level IV |
1 | 1 |
$171,000 |
| Cytokinetics, Inc. |
Level III |
1 | 1 |
$140,000 |
| Eikon Therapeutics, Inc. |
Level I |
1 | 1 |
$78,270 |
| Eli Lilly and Company |
Level IV |
1 | 1 |
$151,525 |
| Eurofins Professional Scientific Services West, LLC |
Level I |
1 | 1 |
$79,040 |
| Genentech, Inc. |
Level IV |
1 | 1 |
$148,117 |
| Glyphic Biotechnologies, Inc. |
Level IV |
1 | 1 |
$150,000 |
| Insitro, Inc. |
Level IV |
1 | 1 |
$148,117 |
| IsoRX Texas LTD |
Level I |
1 | 1 |
$78,270 |
| Leland Stanford Jr. Univ/SLAC National Accelerator Lab |
Level III |
1 | 1 |
$149,282 |
| MRL San Francisco, LLC |
Level IV |
1 | 1 |
$148,117 |
| Nosis Biological Sciences Inc. |
Level II |
1 | 1 |
$101,546 |
| Novartis Institutes for BioMedical Research, Inc. |
Level III |
1 | 1 |
$124,842 |
| Nurix Therapeutics, Inc. |
Level III |
1 | 1 |
$165,000 |
| Onepot AI, Inc. |
Level III |
1 | 1 |
$170,000 |
| PACIFIC BIOLABS, INC. |
Level II |
1 | 1 |
$114,500 |
| Pacific Biosciences of California, Inc. |
Level II |
1 | 1 |
$117,266 |
| Revance Therapeutics, Inc. |
Level II |
1 | 1 |
$101,546 |
| Roche Sequencing Solutions, Inc. |
Level IV |
1 | 1 |
$150,051 |
| Seagate US LLC |
Level IV |
1 | 1 |
$158,725 |
| Seer, Inc. |
Level IV |
1 | 1 |
$148,117 |
| Sepion Technologies, Inc. |
Level III |
1 | 1 |
$130,000 |
| University of California, San Francisco |
Level II |
1 | 1 |
$130,000 |
| C S BIO CO. |
Level I |
1 | 1 |
$74,000 |
| Tecan Genomics, Inc. |
Level III |
1 | 1 |
$120,000 |
| Vilya, Inc. |
Level II |
1 | 1 |
$95,264 |
| University of California, Berkeley |
not stated |
10 | 10 |
$85,000 |
| Lawrence Berkeley National Laboratory |
not stated |
5 | 5 |
$88,044 |
| Gilead Sciences, Inc |
not stated |
2 | 2 |
$129,456,929 |
| University of California, San Francisco |
not stated |
1 | 1 |
$82,836 |